P2RX7 plays a critical role in extracellular vesicle‐mediated secretion of pathogenic molecules from microglia and astrocytes
Journal of Extracellular Biology · 2024-07 · 3 (7)
DOI: 10.1002/jex2.155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Biology, online erschienen am 27.06.2024. Verfasst von Mohammad Abdullah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience Mayo Clinic Florida Jacksonville Florida USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging, Cure Alzheimer's Fund.
Abstract (Originalsprache)
Extracellular vesicle (EV) secretion is mediated by purinergic receptor P2X 7 (P2RX7), an ATP‐gated cation channel highly expressed in microglia. We have previously shown that administration of GSK1482160, a P2RX7 selective inhibitor, suppresses EV secretion from murine microglia and prevents tauopathy development, leading to the recovery of the hippocampal function in PS19 mice, expressing P301S tau mutant. It is yet unknown, however, whether the effect of GSK1482160 on EV secretion from glial cells is specifically regulated through P2RX7. Here we tested GSK1482160 on primary microglia and astrocytes isolated from C57BL/6 (WT) and P2rx7 –/– mice and evaluated their EV secretion and phagocytotic activity of aggregated human tau (hTau) under ATP stimulation. GSK1482160 treatment and deletion of P2rx7 significantly reduced secretion of small and large EVs in microglia and astrocytes in both ATP stimulated or unstimulated condition as determined by nanoparticle tracking analysis, CD9 ELISA and immunoblotting of Tsg101 and Flotilin 1 using isolated EVs. GSK1482160 treatment had no effect on EV secretion from P2rx7 –/– microglia while we observed significant reduction in the secretion of small EVs from P2rx7 –/– astrocytes, suggesting its specific targeting of P2RX7 in EV secretion except small EV secretion from astrocytes. Finally, deletion of P2rx7 suppressed IL‐1β secretion and phagocytosed misfolded tau from both microglia and astrocytes. Together, these findings show that GSK1482160 suppresses EV secretion from microglia and astrocytes in P2RX7‐dependment manner, and P2RX7 critically regulates secretion of IL‐1β and misfolded hTau, demonstrating as the viable target of suppressing EV‐mediated neuroinflammation and tau propagation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neuroscience Mayo Clinic Florida Jacksonville Florida USA.
- Regenerative Science Graduate Program Mayo Clinic College of Medicine and Science Jacksonville Florida USA.
ORCID-Profile: Tsuneya Ikezu
Förderung
- NIA NIH HHS
- National Institute on Aging
- Cure Alzheimer's Fund
Zitieren
APA
Abdullah, M., Ruan, Z., Ikezu, S., & Ikezu, T. (2024). P2RX7 plays a critical role in extracellular vesicle‐mediated secretion of pathogenic molecules from microglia and astrocytes. Journal of Extracellular Biology, 3(7). https://doi.org/10.1002/jex2.155
Vancouver
Abdullah M, Ruan Z, Ikezu S, Ikezu T. P2RX7 plays a critical role in extracellular vesicle‐mediated secretion of pathogenic molecules from microglia and astrocytes. Journal of Extracellular Biology. 2024;3(7). doi:10.1002/jex2.155
BibTeX
@article{Abdullah2024,
author = {Abdullah, Mohammad and Ruan, Zhi and Ikezu, Seiko and Ikezu, Tsuneya},
title = {P2RX7 plays a critical role in extracellular vesicle‐mediated secretion of pathogenic molecules from microglia and astrocytes},
journal = {Journal of Extracellular Biology},
year = {2024},
volume = {3},
number = {7},
doi = {10.1002/jex2.155}
}
EUVIMED